跳到正文
原文
U.S. FDA· @FDA · X·· 20 天前精选AI 评分40
AI 导读

FDA宣布启动罕见病框架计划(Rare Disease Framework Initiative),并与Reagan Udall基金会联合举办首场公开会议,征集各方意见。FDA表示目前仅5%的罕见病拥有获批疗法,现状不足以应对需求。FDA代理局长KyleD在会上称,需求的紧迫性未变,监管机构、药物开发者、研究人员与患者已准备好共同应对。

推荐理由

FDA启动罕见病框架计划,并给出仅5%罕见病有获批疗法的背景,读者可据此了解该监管举措的出发点。

正文

Today, FDA kicked off its Rare Disease Framework Initiative with a public meeting, co-hosted by @ReaganUdall. Thanks to all who joined for your input, candor & vision. With only 5% of rare diseases having an approved treatment, the status quo isn't enough — we must do more.

FDA Acting Commissioner @FDA_KyleD shared with the attendees that the “urgency of the need has not changed, but now we — the agency, drug developers, researchers, and patients — are ready to meet that need together.”

来源:U.S. FDA · x.com